(Q44983891)

8 December 2017

title

Cost-effectiveness and long-term effectiveness of internet-based cognitive behaviour therapy for severe health anxiety (English)

1 reference

8 December 2017

E Andersson

2

0 references

Brjánn Ljótsson

object named as

B Ljótsson

6

0 references

Christian Rück

object named as

C Rück

5

0 references

Gerhard Andersson

object named as

G Andersson

4

0 references

author name string

E Hedman

1

1 reference

8 December 2017

N Lindefors

3

1 reference

8 December 2017

language of work or name

English

0 references

publication date

21 May 2012

1 reference

8 December 2017

published in

Psychological Medicine

1 reference

8 December 2017

volume

43

1 reference

8 December 2017

issue

2

1 reference

8 December 2017

page(s)

363-374

1 reference

Prevalence and service implications of health anxiety in genitourinary medicine clinics.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Two psychological treatments for hypochondriasis. A randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

A roadmap to computer-based psychotherapy in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

A prospective 4- to 5-year study of DSM-III-R hypochondriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Cognitive behavior therapy for hypochondriasis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Anxiety sensitivity, anxiety frequency and the prediction of fearfulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Cost-effectiveness of preventing depression in primary care patients: randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

EQ-5D: a measure of health status from the EuroQol Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Computerized, interactive, multimedia cognitive-behavioural program for anxiety and depression in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Using the Internet to provide cognitive behaviour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

A comparison of two methods of collecting economic data in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

A Proof for the Queuing Formula:L= λW

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Incremental cost-effectiveness of a collaborative care intervention for panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Internet-based cognitive–behavioural therapy for severe health anxiety: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Guided and unguided self-help for social anxiety disorder: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Epidemiology of somatoform disorders: a community survey in Florence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

A controlled trial of cognitive-behavioural treatment of hypochondriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

Modeling valuations for EuroQol health states

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

GEOGRAPHIC INEQUITY IN THE AVAILABILITY OF COGNITIVE BEHAVIOURAL THERAPY IN ENG LAND AND WALES

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

A taxometric analysis of health anxiety

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

Dimensions of Hypochondriasis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

An inventory for measuring clinical anxiety: psychometric properties

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

U.S. health care spending in an international context

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

A validation study of the Whitely Index, the Illness Attitude Scales, and the Somatosensory Amplification Scale in general medical and general practice patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712001079

7 January 2021

10.1017/S0033291712001079

Identifiers

DOI

1 reference

8 December 2017

1 reference